SCHEMBL2051501

SCHEMBL2051501

CSc1nccc(-c2c[nH]nc2-c2ccc(Cl)s2)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.53
CCNT1 O60563 1/20 0.42
CCNA2 P20248 1/20 0.42
CDK2 P24941 1/20 0.42
CDK9 P50750 1/20 0.42
CCNA1 P78396 1/20 0.42
CDK5 Q00535 1/20 0.42
CDK5R1 Q15078 1/20 0.42
GABRA1 P14867 1/20 0.41
L3MBTL1 Q9Y468 3/20 0.37
ALDH1A1 P00352 2/20 0.37
MEN1 O00255 1/20 0.37
MAPT P10636 1/20 0.37
KMT2A Q03164 1/20 0.37
POLB P06746 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
KDM4E B2RXH2 3/20 0.35
GAA P10253 2/20 0.35
CSNK1E P49674 1/20 0.34
PFKFB4 Q16877 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2050535 0.78 MAPK8 (0.46) L3MBTL1ALDH1A1MEN1MAPTKMT2A
SCHEMBL3255992 0.76 LMNA (0.47) LMNACCNT1CCNA2CDK2CDK9
SCHEMBL2051205 0.76 LMNA (0.50) LMNACCNT1CCNA2CDK2CDK9
SCHEMBL1554639 0.74 MAPK14 (0.54) LMNACCNT1CCNA2CDK2CDK9
SCHEMBL5205411 0.74 CCNT1 (0.44) LMNACCNT1CCNA2CDK2CDK9
SCHEMBL8237569 0.74 CCNA2 (0.51) LMNACCNT1CCNA2CDK2CDK9
SCHEMBL14947686 0.74 CCNA2 (0.51) LMNACCNT1CCNA2CDK2CDK9
SCHEMBL3917686 0.73 CCNT1 (0.44) LMNACCNT1CCNA2CDK2CDK9
SCHEMBL13382569 0.73 CCNT1 (0.49) LMNACCNT1CCNA2CDK2CDK9
SCHEMBL8233834 0.72 CCNA2 (0.50) LMNACCNT1CCNA2CDK2CDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2516423-A1 THIENYLPYRI (MI) DINYLAZOLE AND THEIR USE FOR CONTROLLING PHYTOPATHOGENIC FUNGI Bayer CropScience AG (DE) 2012-10-31 EP disclosed
US-20110237588-A1 Thienylpyri(mi)dinylazole BAYER CROPSCIENCE AG (DE) 2011-09-29 US disclosed
WO-2011076725-A1 THIENYLPYRI (MI) DINYLAZOLE AND THEIR USE FOR CONTROLLING PHYTOPATHOGENIC FUNGI BAYER CROPSCIENCE AG (DE) 2011-06-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237588-A1 Thienylpyri(mi)dinylazole PADI1, TH, H1-3 LMNA 3773/4885CCNT1 36/4885CCNA2 970/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.